Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal



Page Path
HOME > Search
5 "Bariatric surgery"
Article category
Publication year
Funded articles
Original Articles
Article image
Change Profiles and Functional Targets of MicroRNAs in Type 2 Diabetes Mellitus Patients with Obesity
Guanhua Lu, Huanhuan Gao, Zhiyong Dong, Shuwen Jiang, Ruixiang Hu, Cunchuan Wang
Diabetes Metab J. 2023;47(4):559-570.   Published online April 25, 2023
  • 1,941 View
  • 79 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
MicroRNAs (miRNAs) exert an essential contribution to obesity and type 2 diabetes mellitus (T2DM). This study aimed to investigate the differences of miRNAs in the presence and absence of T2DM in patients with obesity, as well as before and after bariatric surgery in T2DM patients with obesity. Characterization of the common changes in both was further analyzed.
We enrolled 15 patients with obesity but without T2DM and 15 patients with both obesity and T2DM. Their preoperative clinical data and serum samples were collected, as well as 1 month after bariatric surgery. The serum samples were analyzed by miRNA sequencing, and the miRNAs profiles and target genes characteristics were compared.
Patients with T2DM had 16 up-regulated and 32 down-regulated miRNAs compared to patients without T2DM. Improvement in metabolic metrics after bariatric surgery of T2DM patients with obesity was correlated with changes in miRNAs, as evidenced by the upregulation of 20 miRNAs and the downregulation of 30 miRNAs. Analysis of the two miRNAs profiles identified seven intersecting miRNAs that showed opposite changes. The target genes of these seven miRNAs were substantially enriched in terms or pathways associated with T2DM.
We determined the expression profiles of miRNAs in the obese population, with and without diabetes, before and after bariatric surgery. The miRNAs that intersected in the two comparisons were discovered. Both the miRNAs discovered and their target genes were closely associated with T2DM, demonstrating that they might be potential targets for the regulation of T2DM.
Article image
Glucose Profiles Assessed by Intermittently Scanned Continuous Glucose Monitoring System during the Perioperative Period of Metabolic Surgery
Kyuho Kim, Sung Hee Choi, Hak Chul Jang, Young Suk Park, Tae Jung Oh
Diabetes Metab J. 2022;46(5):713-721.   Published online January 24, 2022
  • 5,331 View
  • 329 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Continuous glucose monitoring (CGM) has been widely used in the management of diabetes. However, the usefulness and detailed data during perioperative status were not well studied. In this study, we described the immediate changes of glucose profiles after metabolic surgery using intermittently scanned CGM (isCGM) in individuals with type 2 diabetes mellitus (T2DM).
This was a prospective, single-center, single-arm study including 20 participants with T2DM. The isCGM (FreeStyle Libre CGM) implantation was performed within 2 weeks before surgery. We compared CGM metrics of 3 days before surgery and 3 days after surgery, and performed the correlation analyses with clinical variables.
The mean glucose significantly decreased after surgery (147.0±40.4 to 95.5±17.1 mg/dL, P<0.001). Time in range (TIR; 70 to 180 mg/dL) did not significantly change after surgery in total. However, it was significantly increased in a subgroup of individuals with glycosylated hemoglobin (HbA1c) ≥8.0%. Time above range (>250 or 180 mg/dL) was significantly decreased in total. In contrast, time below range (<70 or 54 mg/dL) was significantly increased in total and especially in a subgroup of individuals with HbA1c <8.0% after surgery. The coefficient of variation significantly decreased after surgery. Higher baseline HbA1c was correlated with greater improvement in TIR (rho=0.607, P=0.005).
The isCGM identified improvement of mean glucose and glycemic variability, and increase of hypoglycemia after metabolic surgery, but TIR was not significantly changed after surgery. We detected an increase of TIR only in individuals with HbA1c ≥8.0%.


Citations to this article as recorded by  
  • Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis
    Ji Soo Kim, Gyeongsil Lee, Kyung-Il Park, Seung-Won Oh
    Diabetes & Metabolism Journal.2024; 48(2): 312.     CrossRef
  • Use of Continuous Glucose Monitoring in Patients Following Bariatric Surgery: A Scoping Review
    Yang Yu, Susan W. Groth
    Obesity Surgery.2023; 33(8): 2573.     CrossRef
  • Asymptomatic Hypoglycemia after Metabolic Surgery: New Insights from Perioperative Continuous Glucose Monitoring
    Sang-Man Jin
    Diabetes & Metabolism Journal.2022; 46(5): 675.     CrossRef
Obesity and Metabolic Syndrome
Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia
Wei-Jei Lee, Lwin Aung
Diabetes Metab J. 2016;40(6):433-443.   Published online December 2, 2016
  • 4,267 View
  • 75 Download
  • 15 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   

Type 2 diabetes mellitus (T2DM) is a current global health priority and Asia is the epicenter of this epidemic disease. Unlike in the west, where older population is most affected, the burden of diabetes in Asian countries is disproportionately high in young to middle-age adults. The incidence of diabetic nephropathy is alarmingly high in patients with early onset T2DM, especially in those with poor glycemic control. How to control this chronic and debilitating disease is currently a very important health issue in Asia. Bariatric surgery has proven successful in treating not just obesity but also T2DM in morbid obese patients (body mass index [BMI] >35 kg/m2). Gastrointestinal metabolic surgery recently has been proposed as a new treatment modality for obesity related T2DM for patients with BMI <35 kg/m2. Many studies from Asia reported promising results of metabolic surgery to treat obese patients with T2DM which is not well controlled. It has been demonstrated that changes in gastrointestinal hormone secretion after gastrointestinal surgery would favor an early improvement of T2DM in Asians. New procedures have also been designed and proposed specifically for the treatment of diabetes in Asia. This article examines clinical trial data and accepted algorithms with a view toward elucidating the application of metabolic surgery for the treatment of T2DM in the Asia. We propose a systematic approach to surgical treatment, addressing current evidences, patient selection, procedure of choice, and timing and guideline for new procedures.


Citations to this article as recorded by  
  • Insulin resistance levels predicted metabolic improvement and weight loss after metabolic surgery in Chinese patients with type 2 diabetes
    Yaoquan Cao, Ping Luo, Haibo Tang, Pengzhou Li, Guohui Wang, Weizheng Li, Zhi Song, Zhihong Su, Xulong Sun, Xianhao Yi, Zhibing Fu, Beibei Cui, Shaihong Zhu, Liyong Zhu
    Surgery for Obesity and Related Diseases.2024; 20(1): 80.     CrossRef
  • Long‐term outcomes of metabolic surgery in overweight and obese patients with type 2 diabetes in Asia
    Yu‐Min Huang, Yen‐Kuang Lin, Wei‐Jei Lee, Kyoung Yul Hur, Kazunori Kasama, Anton Kui Sing Cheng, Ming‐Hsien Lee, Simon Kin‐Hung Wong, Tien‐Chou Soong, Kuo‐Ting Lee, Davide Lomanto, Muffazal Lakdawala, Yen‐Hao Su, Weu Wang
    Diabetes, Obesity and Metabolism.2021; 23(3): 742.     CrossRef
  • Vertical sleeve gastrectomy induces distinctive transcriptomic responses in liver, fat and muscle
    Chang Ho Ahn, Eun Hye Choi, Hyunjung Lee, Woochan Lee, Jong-Il Kim, Young Min Cho
    Scientific Reports.2021;[Epub]     CrossRef
  • Insulin Resistance Remission Following Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy in Chinese Type 2 Diabetes Mellitus Patients With a Body Mass Index of 27.5–32.5 kg/m2
    Ping Luo, Yaoquan Cao, Pengzhou Li, Guohui Wang, Zhi Song, Weizheng Li, Zhihong Su, Hui Zhou, Xianhao Yi, Zhibing Fu, Xulong Sun, Haibo Tang, Beibei Cui, Qianqian Yu, Liyong Zhu, Shaihong Zhu
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Pre- and postoperative respiratory muscle strength, body mass index and fasting glucose profile of patients with type 2 diabetes mellitus submitted to metabolic surgery
    Ariana de Melo Tosta, Marisa de Carvalho Borges, Élida Mara Carneiro da Silva, Alex Augusto da Silva, Eduardo Crema
    Fisioterapia em Movimento.2020;[Epub]     CrossRef
  • Outcomes After Metabolic Surgery in Asians—a Meta-analysis
    Danson Yeo, Charleen Yeo, Tze Yi Low, Saleem Ahmed, Sheena Phua, Aung Myint Oo, Jaideepraj Rao, Aaryan Koura, Kavita Venkataraman, Sanghvi Kaushal
    Obesity Surgery.2019; 29(1): 114.     CrossRef
  • Diabetes resolution after one anastomosis gastric bypass
    Adam Abu-Abeid, Yonatan Lessing, Niv Pencovich, Danit Dayan, Joseph M. Klausner, Subhi Abu-Abeid
    Surgery for Obesity and Related Diseases.2018; 14(2): 181.     CrossRef
  • Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis
    Zhiyong Dong, Sheikh Mohammed Shariful Islam, Ashley M. Yu, Rui Qu, Bingsheng Guan, Junchang Zhang, Zhao Hong, Cunchuang Wang
    BMC Surgery.2018;[Epub]     CrossRef
  • Clinical Practice Recommendations for the Management of Obesity in the United Arab Emirates
    Salahedeen Abusnana, Mohammad Fargaly, Shaima Hasan Alfardan, Fatema Hasan Al Hammadi, Alaaeldin Bashier, Ghaida Kaddaha, Barbara McGowan, Rita Nawar, Amena Sadiya
    Obesity Facts.2018; 11(5): 413.     CrossRef
  • Laparoscopic sleeve gastrectomy combined with single-anastomosis duodenal-jejunal bypass in the treatment of type 2 diabetes mellitus of patients with body mass index higher than 27.5 kg/m2 but lower than 32.5 kg/m2
    Ying-Xu Li, Deng-Hua Fang, Tian-Xi Liu
    Medicine.2018; 97(31): e11537.     CrossRef
  • Comparison of Great Curvature Plication with Duodenal-Jejunal Bypass (GCP-DJB) and Sleeve Gastrectomy (SG) on Metabolic Indices and Gut Hormones in Type 2 Diabetes Mellitus Rats
    Nian-Cun Qiu, Wei Li, Miao-E Liu, Xiao-Xia Cen, Cheng-Xiang Shan, Wei Zhang, Qing Liu, Yang Wang, Ya-Ting Zhu, Ming Qiu
    Obesity Surgery.2018; 28(12): 4014.     CrossRef
  • Evolution of Diabetes Care in Hong Kong: From the Hong Kong Diabetes Register to JADE-PEARL Program to RAMP and PEP Program
    Ivy H.Y. Ng, Kitty K.T. Cheung, Tiffany T.L. Yau, Elaine Chow, Risa Ozaki, Juliana C.N. Chan
    Endocrinology and Metabolism.2018; 33(1): 17.     CrossRef
  • Ethnicity Does Not Influence Glycemic Outcomes or Diabetes Remission After Sleeve Gastrectomy or Gastric Bypass in a Multiethnic Asian Cohort
    Phong Ching Lee, Kwang Wei Tham, Sonali Ganguly, Hong Chang Tan, Alvin Kim Hock Eng, John B. Dixon
    Obesity Surgery.2018; 28(6): 1511.     CrossRef
  • Effects of GABAB receptor activation on spatial cognitive function and hippocampal neurones in rat models of type 2 diabetes mellitus
    Xiao-Jun Cai, Lei Wang, Chun-Mei Hu
    Bioscience Reports.2018;[Epub]     CrossRef
  • Metabolic surgery ameliorates cardiovascular risk in obese diabetic patients: Influence of different surgical procedures
    Jih-Hua Wei, Ruey-Hsing Chou, Po-Hsun Huang, Wei-Jei Lee, Shu-Chun Chen, Shing-Jong Lin
    Surgery for Obesity and Related Diseases.2018; 14(12): 1832.     CrossRef
  • Pulmonary function evaluation in type 2 diabetes mellitus patients submitted to metabolic surgery
    Ariana de Melo Tosta, Marisa de Carvalho Borges, Élida Mara Carneiro da Silva, Tharsus Dias Takeuti, Júverson Alves Terra Júnior, Eduardo Crema
    Fisioterapia em Movimento.2018;[Epub]     CrossRef
The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?
Dora M. Gorman, Carel W. le Roux, Neil G. Docherty
Diabetes Metab J. 2016;40(5):354-364.   Published online September 27, 2016
  • 4,589 View
  • 49 Download
  • 24 Web of Science
  • 28 Crossref
AbstractAbstract PDFPubReader   

Bariatric surgery, initially intended as a weight-loss procedure, is superior to standard lifestyle intervention and pharmacological therapy for type 2 diabetes in obese individuals. Intensive medical management of hyperglycemia is associated with improved microvascular outcomes. Whether or not the reduction in hyperglycemia observed after bariatric surgery translates to improved microvascular outcomes is yet to be determined. There is substantial heterogeneity in the data relating to the impact of bariatric surgery on diabetic retinopathy (DR), the most common microvascular complication of diabetes. This review aims to collate the recent data on retinal outcomes after bariatric surgery. This comprehensive evaluation revealed that the majority of DR cases remain stable after surgery. However, risk of progression of pre-existing DR and the development of new DR is not eliminated by surgery. Instances of regression of DR are also noted. Potential risk factors for deterioration include severity of DR at the time of surgery and the magnitude of glycated hemoglobin reduction. Concerns also exist over the detrimental effects of postprandial hypoglycemia after surgery. In vivo studies evaluating the chronology of DR development and the impact of bariatric surgery could provide clarity on the situation. For now, however, the effect of bariatric surgery on DR remains inconclusive.


Citations to this article as recorded by  
  • Author response to: remission of diabetes mellitus after bariatric surgery: the putative link with worsening diabetic retinopathy and a need for ongoing postoperative follow-up retinal screening
    Karl Hage, Omar M. Ghanem
    Surgery for Obesity and Related Diseases.2024; 20(5): 499.     CrossRef
  • Impact of Bariatric Surgery on Treatment Burden and Progression of Diabetic Retinopathy
    Ariana Allen, Hemal Patel, Sandra S. Stinnett, Jullia A. Rosdahl, Stefanie Schuman
    Journal of VitreoRetinal Diseases.2024; 8(3): 263.     CrossRef
  • Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment
    Joe Mellor, Anita Jeyam, Joline W.J. Beulens, Sanjeeb Bhandari, Geoffrey Broadhead, Emily Chew, Ward Fickweiler, Amber van der Heijden, Daniel Gordin, Rafael Simó, Janet Snell-Bergeon, Anniina Tynjälä, Helen Colhoun
    Ophthalmology Science.2024; 4(4): 100494.     CrossRef
  • The Importance of Glycaemic Control Before Bariatric Surgery: Preventing Microvascular and Metabolic Complications
    Adhithya Sankar, Rajshekhar N. Mudaliar, Rupinder S. Kochhar, Lucinda K. M. Summers, Akheel A. Syed, Waseem Majeed
    Obesity Surgery.2024; 34(6): 2248.     CrossRef
  • Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes
    Rafael Simó, Josep Franch-Nadal, Bogdan Vlacho, Jordi Real, Ester Amado, Juana Flores, Manel Mata-Cases, Emilio Ortega, Mercedes Rigla, Joan-Anton Vallés, Cristina Hernández, Didac Mauricio
    Diabetes Care.2023; 46(9): 1633.     CrossRef
  • Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates
    Kalie L. Tommerdahl, Allison L. B. Shapiro, Edward J. Nehus, Petter Bjornstad
    Pediatric Nephrology.2022; 37(1): 79.     CrossRef
  • New Insights into Treating Early and Advanced Stage Diabetic Retinopathy
    Rafael Simó, Cristina Hernández
    International Journal of Molecular Sciences.2022; 23(15): 8513.     CrossRef
  • Response to Letter to the Editor Concerning: Adam S. et al. Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort Study
    Safwaan Adam, Jan Hoong Ho, Akheel A. Syed, Rayaz A. Malik, Handrean Soran
    Obesity Surgery.2022; 32(10): 3460.     CrossRef
  • Weight management and multi-morbidity
    Carrie Ashby
    InnovAiT: Education and inspiration for general practice.2021; 14(8): 523.     CrossRef
  • The Safety of Pharmacological and Surgical Treatment of Diabetes in Patients with Diabetic Retinopathy—A Review
    Wojciech Matuszewski, Angelika Baranowska-Jurkun, Magdalena Maria Stefanowicz-Rutkowska, Katarzyna Gontarz-Nowak, Ewa Gątarska, Elżbieta Bandurska-Stankiewicz
    Journal of Clinical Medicine.2021; 10(4): 705.     CrossRef
  • Safety of Semaglutide
    Mark M. Smits, Daniël H. Van Raalte
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Outcomes of Diabetic Retinopathy Post-Bariatric Surgery in Patients with Type 2 Diabetes Mellitus
    Ana Maria Dascalu, Anca Pantea Stoian, Alina Popa Cherecheanu, Dragos Serban, Daniel Ovidiu Costea, Mihail Silviu Tudosie, Daniela Stana, Denisa Tanasescu, Alexandru Dan Sabau, Gabriel Andrei Gangura, Andreea Cristina Costea, Vanessa Andrada Nicolae, Cata
    Journal of Clinical Medicine.2021; 10(16): 3736.     CrossRef
  • Future perspectives in diabesity treatment: Semaglutide, a glucagon‑like peptide 1 receptor agonist (Review)
    Mariana Tilinca, Robert Tiuca, Cristina Niculas, Andreea Varga, Ioan Tilea
    Experimental and Therapeutic Medicine.2021;[Epub]     CrossRef
  • Safety of injectable semaglutide for type 2 diabetes
    Rajesh Peter, Steve C. Bain
    Expert Opinion on Drug Safety.2020; 19(7): 785.     CrossRef
  • Early worsening of diabetic retinopathy due to intensive glycaemic control
    Shueh Wen Lim, Peter van Wijngaarden, Colin A. Harper, Salmaan H. Al‐Qureshi
    Clinical & Experimental Ophthalmology.2019; 47(2): 265.     CrossRef
  • Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review
    Stephen C. Bain, Michael A. Klufas, Allen Ho, David R. Matthews
    Diabetes, Obesity and Metabolism.2019; 21(3): 454.     CrossRef
  • Diabetische Retinopathie bei Patienten mit Diabetes mellitus
    Olga Simó-Servat, Cristina Hernández, Rafael Simó
    Kompass Ophthalmologie.2019; 5(4): 157.     CrossRef
  • Diabetic Retinopathy in the Context of Patients with Diabetes
    Olga Simó-Servat, Cristina Hernández, Rafael Simó
    Ophthalmic Research.2019; 62(4): 211.     CrossRef
  • MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass
    Adrian T Billeter, Javier R de la Garza Herrera, Katharina M Scheurlen, Felix Nickel, Franck Billmann, Beat P Müller-Stich
    European Journal of Endocrinology.2018; 179(2): R77.     CrossRef
  • Aggravation précoce de la rétinopathie diabétique lors de l’optimisation du contrôle glycémique
    S. Feldman-Billard
    Médecine des Maladies Métaboliques.2018; 12(7): 560.     CrossRef
  • Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
    Tina Vilsbøll, Stephen C. Bain, Lawrence A. Leiter, Ildiko Lingvay, David Matthews, Rafael Simó, Ida Carøe Helmark, Nelun Wijayasinghe, Michael Larsen
    Diabetes, Obesity and Metabolism.2018; 20(4): 889.     CrossRef
  • Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy
    Antonios Douros, Kristian B. Filion, Hui Yin, Oriana Hoi Yu, Mahyar Etminan, Jacob A. Udell, Laurent Azoulay
    Diabetes Care.2018; 41(11): 2330.     CrossRef
  • Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes
    S. Feldman-Billard, É. Larger, P. Massin
    Diabetes & Metabolism.2018; 44(1): 4.     CrossRef
  • Excess visceral adiposity is associated with diabetic retinopathy in a multiethnic Asian cohort with longstanding type 2 diabetes
    Angela Moh, Kumari Neelam, Xiao Zhang, Chee Fang Sum, Subramaniam Tavintharan, Keven Ang, Simon Biing Ming Lee, Wern Ee Tang, Su Chi Lim
    Endocrine Research.2018; 43(3): 186.     CrossRef
  • GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe?
    Rafael Simó, Cristina Hernández
    Diabetes.2017; 66(6): 1453.     CrossRef
  • The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis
    Binwu Sheng, Khoa Truong, Hugh Spitler, Lu Zhang, Xuetao Tong, Liwei Chen
    Obesity Surgery.2017; 27(10): 2724.     CrossRef
  • Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy
    M. A. Stefater, T. H. Inge
    Current Diabetes Reports.2017;[Epub]     CrossRef
  • The role of bariatric surgery to treat diabetes: current challenges and perspectives
    Chrysi Koliaki, Stavros Liatis, Carel W. le Roux, Alexander Kokkinos
    BMC Endocrine Disorders.2017;[Epub]     CrossRef
A Gut Feeling to Cure Diabetes: Potential Mechanisms of Diabetes Remission after Bariatric Surgery
Young Min Cho
Diabetes Metab J. 2014;38(6):406-415.   Published online December 15, 2014
  • 5,519 View
  • 58 Download
  • 54 Web of Science
  • 42 Crossref
AbstractAbstract PDFPubReader   

A cure for type 2 diabetes was once a mere dream but has now become a tangible and achievable goal with the unforeseen success of bariatric surgery in the treatment of both obesity and type 2 diabetes. Popular bariatric procedures such as Roux-en-Y gastric bypass and sleeve gastrectomy exhibit high rates of diabetes remission or marked improvement in glycemic control. However, the mechanism of diabetes remission following these procedures is still elusive and appears to be very complex and encompasses multiple anatomical and physiological changes. In this article, calorie restriction, improved β-cell function, improved insulin sensitivity, and alterations in gut physiology, bile acid metabolism, and gut microbiota are reviewed as potential mechanisms of diabetes remission after Roux-en-Y gastric bypass and sleeve gastrectomy.


Citations to this article as recorded by  
  • The Effect of Diet Composition on the Post-operative Outcomes of Roux-en-Y Gastric Bypass in Mice
    Matthew Stevenson, Ankita Srivastava, Maria Nacher, Christopher Hall, Thomas Palaia, Jenny Lee, Chaohui Lisa Zhao, Raymond Lau, Mohamed A. E. Ali, Christopher Y. Park, Florencia Schlamp, Sean P. Heffron, Edward A. Fisher, Collin Brathwaite, Louis Ragolia
    Obesity Surgery.2024; 34(3): 911.     CrossRef
  • A Matched Comparative Analysis of Type-2 Diabetes Mellitus Remission Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
    Karl Hage, Pearl Ma, Wissam Ghusn, Kayla Ikemiya, Andres Acosta, Robert A. Vierkant, Barham K. Abu Dayyeh, Kelvin D. Higa, Omar M. Ghanem
    Surgical Innovation.2024; 31(2): 148.     CrossRef
  • Comparison of Sleeve Gastrectomy with Loop Duodenojejunal Bypass Versus One Anastomosis Gastric Bypass for Type 2 Diabetes: The Role of Pylorus Preservation
    Yiming Si, Shibo Lin, Wei Guan, JiaJia Shen, Hui Liang
    Obesity Surgery.2024;[Epub]     CrossRef
  • Sex-Specific Changes in Body Composition Following Metabolic and Bariatric Surgery Are Associated with the Remission of Metabolic Syndrome
    Xianhao Yi, Weizheng Li, Guohui Wang, Pengzhou Li, Xulong Sun, Haibo Tang, Beibei Cui, Jiapu Ling, Ping Luo, Zhibing Fu, Hui Zhou, Liyong Zhu, Shaihong Zhu
    Obesity Surgery.2023; 33(9): 2780.     CrossRef
  • East Asian perspectives in metabolic and bariatric surgery
    Tae Jung Oh, Hyuk‐Joon Lee, Young Min Cho
    Journal of Diabetes Investigation.2022; 13(5): 756.     CrossRef
  • Long-Term Trajectories in Weight and Health Outcomes Following Multidisciplinary Publicly Funded Bariatric Surgery in Patients with Clinically Severe Obesity (≥ 3 Associated Comorbidities): A Nine-Year Prospective Cohort Study in Australia
    Michelle M.C. Tan, Xingzhong Jin, Craig Taylor, Adrian K. Low, Philip Le Page, David Martin, Ang Li, David Joseph, Nic Kormas
    Journal of Clinical Medicine.2022; 11(15): 4466.     CrossRef
  • Impact of Bariatric Surgery in Reducing Macrovascular Complications in Severely Obese T2DM Patients
    Salman Hussain, Mohd Shahnawaz Khan, Mohammad Chand Jamali, Ali Nasir Siddiqui, Gaurav Gupta, Md Sarfaraj Hussain, Fohad Mabood Husain
    Obesity Surgery.2021; 31(5): 1929.     CrossRef
  • Vertical sleeve gastrectomy induces distinctive transcriptomic responses in liver, fat and muscle
    Chang Ho Ahn, Eun Hye Choi, Hyunjung Lee, Woochan Lee, Jong-Il Kim, Young Min Cho
    Scientific Reports.2021;[Epub]     CrossRef
  • Which predictors could effect on remission of type 2 diabetes mellitus after the metabolic surgery: A general perspective of current studies?
    Gamze Akkus, Tamer Tetiker
    World Journal of Diabetes.2021; 12(8): 1312.     CrossRef
  • Impact of Metabolic Surgery on Type-2 Diabetes Remission
    Cejana de Abrantes Figueiredo Baiocchi, Diana Aristótelis Rocha de Sá
    Current Diabetes Reviews.2021;[Epub]     CrossRef
  • Ileal Transposition Increases Pancreatic β Cell Mass and Decreases β Cell Senescence in Diet-Induced Obese Rats
    Chang Ho Ahn, Eun Hye Choi, Tae Jung Oh, Young Min Cho
    Obesity Surgery.2020; 30(5): 1849.     CrossRef
  • Does Reconstruction Type After Gastric Resection Matters for Type 2 Diabetes Improvement?
    Mariana Costa, Artur Trovão Lima, Tiago Morais, Rui F. Almeida, Mário Nora, Marta Guimarães, Mariana P. Monteiro
    Journal of Gastrointestinal Surgery.2020; 24(6): 1269.     CrossRef
  • Epidemiology, pathophysiology and etiology of obesity in children and adolescents
    Jessica Kerns, Martin Fisher
    Current Problems in Pediatric and Adolescent Health Care.2020; 50(9): 100869.     CrossRef
  • Obesity in Adolescents and Youth: The Case for and against Bariatric Surgery
    Ahmed Khattab, Mark A. Sperling
    The Journal of Pediatrics.2019; 207: 18.     CrossRef
  • Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials
    Zhamak Khorgami, Saeed Shoar, Alan A. Saber, C. Anthony Howard, Goodarz Danaei, Guido M. Sclabas
    Obesity Surgery.2019; 29(3): 964.     CrossRef
  • Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy
    Shih-Chiang Shen, Weu Wang, Ka-Wai Tam, Hsin-An Chen, Yen-Kuang Lin, Shih-Yun Wang, Ming-Te Huang, Yen-Hao Su
    Obesity Surgery.2019; 29(1): 221.     CrossRef
  • Long-term diabetes outcomes after bariatric surgery—managing medication withdrawl
    Pedro Souteiro, Sandra Belo, Daniela Magalhães, Jorge Pedro, João Sérgio Neves, Sofia Castro Oliveira, Paula Freitas, Ana Varela, Davide Carvalho
    International Journal of Obesity.2019; 43(11): 2217.     CrossRef
  • What is type 2 diabetes?
    Maria Daniela Hurtado, Adrian Vella
    Medicine.2019; 47(1): 10.     CrossRef
  • Intestinal Glucose Absorption Was Reduced by Vertical Sleeve Gastrectomy via Decreased Gastric Leptin Secretion
    Jinpeng Du, Chaojie Hu, Jie Bai, Miaomiao Peng, Qingbo Wang, Ning Zhao, Yu Wang, Guobin Wang, Kaixiong Tao, Geng Wang, Zefeng Xia
    Obesity Surgery.2018; 28(12): 3851.     CrossRef
  • Non-pharmacological Treatment Options in the Management of Diabetes Mellitus
    Arkiath V Raveendran
    European Endocrinology.2018; 14(2): 31.     CrossRef
  • Ileal transposition rapidly improves glucose tolerance and gradually improves insulin resistance in non-obese type 2 diabetic rats
    Hengliang Zhu, Huaiming Wang, Zhihai Zheng, Bailiang Ye, Xiaojiao Ruan, Xiaofeng Zheng, Guoxin Li
    Gastroenterology Report.2018; 6(4): 291.     CrossRef
  • Small Intestinal Bypass Induces a Persistent Weight-Loss Effect and Improves Glucose Tolerance in Obese Rats
    Jiaqing Cao, Quan Ren, Cai Tan, Jinyuan Duan
    Obesity Surgery.2017; 27(7): 1859.     CrossRef
  • Diabetes improvement and resolution following laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a systematic review of randomized controlled trials
    Emma Osland, Rossita Mohamad Yunus, Shahjahan Khan, Breda Memon, Muhammed Ashraf Memon
    Surgical Endoscopy.2017; 31(4): 1952.     CrossRef
  • The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis
    Binwu Sheng, Khoa Truong, Hugh Spitler, Lu Zhang, Xuetao Tong, Liwei Chen
    Obesity Surgery.2017; 27(10): 2724.     CrossRef
  • Long-term effects of duodenojejunal bypass on diabetes in Otsuka Long–Evans Tokushima Fatty rats
    Sang Kuon Lee, Oh-Joo Kwon, Hae Myung Jeon, Say-June Kim
    Asian Journal of Surgery.2017; 40(4): 262.     CrossRef
  • Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
    Stephanie A. Flowers, Simon J. Evans, Kristen M. Ward, Melvin G. McInnis, Vicki L. Ellingrod
    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2017; 37(3): 261.     CrossRef
    Taíse FUCHS, Marcelo LOUREIRO, Gabriela Heloise BOTH, Heloise Helena SKRABA, Thaís Andrade COSTA-CASAGRANDE
    ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo).2017; 30(4): 283.     CrossRef
  • Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
    Satoko Shimazu-Kuwahara, Norio Harada, Shunsuke Yamane, Erina Joo, Akiko Sankoda, Timothy J. Kieffer, Nobuya Inagaki
    Molecular Metabolism.2017; 6(3): 288.     CrossRef
  • Adipose tissue supports normalization of macrophage and liver lipid handling in obesity reversal
    Maayan Vatarescu, Sapir Bechor, Yulia Haim, Tal Pecht, Tanya Tarnovscki, Noa Slutsky, Ori Nov, Hagit Shapiro, Avishai Shemesh, Angel Porgador, Nava Bashan, Assaf Rudich
    Journal of Endocrinology.2017; 233(3): 293.     CrossRef
  • Sleeve Gastrectomy Alters Intestinal Permeability in Diet-Induced Obese Mice
    Claire Blanchard, François Moreau, Julien Chevalier, Audrey Ayer, Damien Garcon, Lucie Arnaud, Jean-Paul Pais de Barros, Thomas Gautier, Michel Neunlist, Bertrand Cariou, Cédric Le May
    Obesity Surgery.2017; 27(10): 2590.     CrossRef
  • Long-term Follow-up for Type 2 Diabetes Mellitus after Gastrectomy in Non-morbidly Obese Patients with Gastric Cancer: the Legitimacy of Onco-metabolic Surgery
    Tae-Hoon Lee, Chang Min Lee, Sungsoo Park, Do Hyun Jung, You Jin Jang, Jong-Han Kim, Seong-Heum Park, Young-Jae Mok
    Journal of Gastric Cancer.2017; 17(4): 283.     CrossRef
  • Preoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery
    Pedro Souteiro, Sandra Belo, João Sérgio Neves, Daniela Magalhães, Rita Bettencourt Silva, Sofia Castro Oliveira, Maria Manuel Costa, Ana Saavedra, Joana Oliveira, Filipe Cunha, Eva Lau, César Esteves, Paula Freitas, Ana Varela, Joana Queirós, Davide Carv
    Obesity Surgery.2017; 27(2): 288.     CrossRef
  • Ileal Transposition Decreases Plasma Lipopolysaccharide Levels in Association with Increased L Cell Secretion in Non-obese Non-diabetic Rats
    Tae Jung Oh, Hyuk-Joon Lee, Young Min Cho
    Obesity Surgery.2016; 26(6): 1287.     CrossRef
  • The Mechanism of Metabolic Surgery: Gastric Center Hypothesis
    Jiangfan Zhu, Radheshyam Gupta, Mahmood Safwa
    Obesity Surgery.2016; 26(7): 1639.     CrossRef
  • Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)
    Harold Bays, Shanu N. Kothari, Dan E. Azagury, John M. Morton, Ninh T. Nguyen, Peter H. Jones, Terry A. Jacobson, David E. Cohen, Carl Orringer, Eric C. Westman, Deborah B. Horn, Wendy Scinta, Craig Primack
    Surgery for Obesity and Related Diseases.2016; 12(3): 468.     CrossRef
  • Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia
    Wei-Jei Lee, Lwin Aung
    Diabetes & Metabolism Journal.2016; 40(6): 433.     CrossRef
  • Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome
    Lukasz Kaska, Tomasz Sledzinski, Agnieszka Chomiczewska, Agnieszka Dettlaff-Pokora, Julian Swierczynski
    World Journal of Gastroenterology.2016; 22(39): 8698.     CrossRef
  • In Vivo Models for Incretin Research: From the Intestine to the Whole Body
    Tae Jung Oh
    Endocrinology and Metabolism.2016; 31(1): 45.     CrossRef
  • Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: Lessons from ileal transposition surgery
    Tae Jung Oh, Chang Ho Ahn, Young Min Cho
    Journal of Diabetes Investigation.2016; 7(S1): 94.     CrossRef
    Cátia Ferreira da SILVA, Larissa COHEN, Luciana d'Abreu SARMENTO, Felipe Monnerat Marino ROSA, Eliane Lopes ROSADO, João Régis Ivar CARNEIRO, Antônio Augusto Peixoto de SOUZA, Fernanda Cristina Carvalho Mattos MAGNO
    ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo).2016; 29( suppl 1): 20.     CrossRef
  • Medication Use Among Patients Prior to Bariatric Surgery
    Jennifer Padden Elliott, Erica L. Gray, Jessie Yu, Melissa A. Kalarchian
    Bariatric Surgical Practice and Patient Care.2015; 10(3): 105.     CrossRef
  • Changes in the salivary protein profile of morbidly obese women either previously subjected to bariatric surgery or not
    Elsa Lamy, Carla Simões, Lénia Rodrigues, Ana Rodrigues Costa, Rui Vitorino, Francisco Amado, Célia Antunes, Isabel do Carmo
    Journal of Physiology and Biochemistry.2015; 71(4): 691.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer